Allergan plc confirms discussions regarding potential business combination transaction with Pfizer Inc.

Allergan plc today confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions will lead to a transaction, or as to the terms on which a transaction, if any, might be agreed.

Hits: 771

Read more ...

AstraZeneca rejects final proposal from Pfizer

The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.

Hits: 8327

Read more ...

Pfizer announcement and AstraZeneca statement

Pfizer wishes to enter into discussions with AstraZeneca regarding a potential combination of the two companies and is "disappointed at the lack of engagement by the AstraZeneca Board". The Board of AstraZeneca notes the announcement made by Pfizer and states that the "announcement contains no new proposal nor substantive new information."

Hits: 6787

Read more ...

Forest Laboratories to Acquire Clinical Data, Inc.

Forest LaboratoriesForest Laboratories, Inc. (Forest) (NYSE: FRX) and Clinical Data, Inc. (Clinical Data) (NASDAQ: CLDA) have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics,

Hits: 6964

Read more ...

Convergence Pharmaceuticals Successfully Launched out of GSK to Focus on Novel High Value Analgesics

Convergence Pharmaceuticals Ltd, a new company focused on the development of novel and high value analgesic medicines, was officially launched and has successfully raised $35.4 million (£22.4 million) in Series A financing from a syndicate of leading European and US life science investors. Convergence Pharmaceuticals is an independent biotechnology company that has acquired clinical assets from GlaxoSmithKline ("GSK").

Hits: 8150

Read more ...

Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business

Mylan Inc. (Nasdaq: MYL) has announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash.

Hits: 5353

Read more ...

Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.

Astellas Pharma Inc.Astellas Pharma Inc. (TSE: 4503), a global pharmaceutical company, and OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes and obesity, have entered into a definitive merger agreement under which Astellas will acquire OSI.

Hits: 5123

Read more ...

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]